Stock A068270 CELLTRION, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Celltrion, Inc.

Equities

A068270

KR7068270008

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-27 pm EDT 		5-day change 1st Jan Change
180,900 KRW +0.72% Intraday chart for Celltrion, Inc. -3.26% -10.22%
May. 24 Celltrion Receives European Commission Approval of Omlyclo® (CT-P39), the First and Only Omalizumab Biosimilar Approved in Europe CI
May. 10 Celltrion's Q1 Attributable Profit Slumps 86% MT

Evolution of the average Target Price on Celltrion, Inc.

Price target over the last 5 years

History of analyst recommendation changes

1d2f601b.p-_kQhvVdq8QOEEmEy_EWjUMjy3_TBFRYvYNMSFEjbI.kIm3BG6eJOIiYjdQIE6bHAU82xqcekNlNJQ-d1QIx_vro6l3crwZmlhnMg~b890b91eb26e37522375f9501be2011e

Analyst Recommendations on Celltrion, Inc.

South Korean Shares Decline After Latest Fed Minutes Indicate Continuation of High-Interest Rates MT
South Korean Shares Close Higher as Investors Look Beyond Further Rate Hike Decision by US Fed; Celltrion Adds 1% MT
South Korean Shares Decline on Concerns over US Fed Rate Hike, China Economic Turmoil MT
South Korean shares track Wall Street higher; Fed rate decision in focus RE
South Korea’s Kospi Gains on US Fed’s Decision to Not Focus on Pace of Rate Hikes MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
180,900 KRW
Average target price
233,647 KRW
Spread / Average Target
+29.16%
High Price Target
300,000 KRW
Spread / Highest target
+65.84%
Low Price Target
172,000 KRW
Spread / Lowest Target
-4.92%

Consensus detail

Consensus revision (last 18 months)

Ratings for Celltrion, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. A068270 Stock
  4. Consensus Celltrion, Inc.